Spot shows folks running as a symbol of how the health-challenged can chase their dreams because of Sanofi meds.

With a new approach to creating thymus-targeted medicines for autoimmune diseases, Zag Bio has emerged from stealth with the ...

Sanofi India Limited ( ($IN:SANOFI) ) has shared an announcement. Sanofi India Limited has announced the appointment of Mr. Deepak Arora as the ...

Q3 2025 Earnings Call October 24, 2025 8:30 AM EDTCompany ParticipantsThomas Larsen - Head of Investor RelationsPaul Hudson - CEO ...

Pharmaceutical launches and increased demand for its blockbuster Dupixent drug lifted net sales by 7% in the third quarter.

Sanofi said new medicine generated sales of 1 billion euros, up 57% from the same period last year. It said sales of the anti-inflammatory treatment Dupixent--developed jointly with Regeneron--jumped ...

Two major names in the biopharma industry are announcing a new deal to boost drug product manufacturing in the U.S. Thermo Fisher Scientific will acquire Sanofi’s steriles manufacturing site in ...

Sanofi will employ Medidata’s expertise and capabilities in decentralized clinical trials as part of this new enterprise agreement. Medidata will also provide strategic consulting and end-to-end ...

The drug’s success in a Phase 2 study in alpha-1 antitrypsin deficiency “validates” Sanofi’s 2024 acquisition of Inhibrx, ...

Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 studyEfdoralprin alfa ...